文献速递心脑血管急症重症综合管理与镇静镇痛

神经丝轻链作为心脏骤停后预后预测指标:COMACARE试验的事后分析

Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial.
PubMed 文献 · Intensive Care Med · 2020-08-27
一句话结论院外心脏骤停后昏迷患者血浆神经丝轻链(NfL)在24-72小时预测6个月不良神经结局的AUROC为0.98,MAP目标80-100 mmHg组NfL较低。

该研究为COMACARE试验的事后分析,纳入112例院外心脏骤停后昏迷患者,在ICU入院时及骤停后24、48、72小时测定血浆NfL浓度,以6个月CPC 1-2为良好结局、CPC 3-5为不良结局。65%患者6个月结局良好;骤停后48小时良好结局组NfL中位数19 pg/ml,不良结局组2343 pg/ml,p<0.001。NfL预测不良结局的AUROC在24、48、72小时均为0.98。较高MAP目标(80-100 mmHg)组48小时NfL中位数低于较低MAP目标(65-75 mmHg)组(23 vs 43 pg/ml,p=0.04);PaCO2和PaO2目标与NfL水平无关。

要点

  • 院外心脏骤停后昏迷患者,骤停后48小时良好结局组NfL中位数19 pg/ml(IQR 11-31),不良结局组2343 pg/ml(IQR 587-5829),p<0.001。
  • NfL预测6个月不良神经结局(CPC 3-5)的AUROC:24小时0.98(95%CI 0.97-1.00)、48小时0.98(0.97-1.00)、72小时0.98(0.95-1.00)。
  • MAP目标80-100 mmHg组48小时NfL中位数23 pg/ml,低于MAP目标65-75 mmHg组的43 pg/ml,p=0.04。
  • PaCO2和PaO2目标与NfL水平无关联。
  • 6个月结局良好者占73/112(65%)。

适用人群与场景

  • 院外心脏骤停后昏迷、收入ICU的患者,来自COMACARE试验人群。

诊断标准与关键阈值

  • 6个月神经结局以脑功能分级(CPC)评估:CPC 1-2定义为良好结局,CPC 3-5定义为不良结局。

研究设计与关键结果

  • 研究类型为COMACARE试验的事后分析,样本量112例院外心脏骤停后昏迷患者。
  • 在ICU入院时及骤停后24、48、72小时测定血浆NfL浓度。
  • 6个月结局良好73/112例(65%)。
  • 骤停后48小时NfL中位数:良好结局组19 pg/ml(IQR 11-31)vs 不良结局组2343 pg/ml(IQR 587-5829),p<0.001。
  • NfL预测不良结局的AUROC:24小时0.98(95%CI 0.97-1.00),48小时0.98(0.97-1.00),72小时0.98(0.95-1.00)。
  • 48小时NfL中位数:较高MAP目标(80-100 mmHg)组23 pg/ml vs 较低MAP目标(65-75 mmHg)组43 pg/ml,p=0.04。
  • PaCO2和PaO2目标与NfL水平无关联。

证据类型、等级与局限

  • 证据类型:COMACARE试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为NfL在院外心脏骤停后表现出优秀的预后准确性。
  • 作者报告较高MAP与较低NfL浓度相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Neurofilament light (NfL) is a biomarker reflecting neurodegeneration and acute neuronal injury, and an increase is found following hypoxic brain damage. We assessed the ability of plasma NfL to predict outcome in comatose patients after out-of-hospital cardiac arrest (OHCA). We also compared plasma NfL concentrations between patients treated with two different targets of arterial carbon dioxide tension (PaCO2), arterial oxygen tension (PaO2), and mean arterial pressure (MAP).

METHODS: We measured NfL concentrations in plasma obtained at intensive care unit admission and at 24, 48, and 72 h after OHCA. We assessed neurological outcome at 6 months and defined a good outcome as Cerebral Performance Category (CPC) 1-2 and poor outcome as CPC 3-5.

RESULTS: Six-month outcome was good in 73/112 (65%) patients. Forty-eight hours after OHCA, the median NfL concentration was 19 (interquartile range [IQR] 11-31) pg/ml in patients with good outcome and 2343 (587-5829) pg/ml in those with poor outcome, p < 0.001. NfL predicted poor outcome with an area under the receiver operating characteristic curve (AUROC) of 0.98 (95% confidence interval [CI] 0.97-1.00) at 24 h, 0.98 (0.97-1.00) at 48 h, and 0.98 (0.95-1.00) at 72 h. NfL concentrations were lower in the higher MAP (80-100 mmHg) group than in the lower MAP (65-75 mmHg) group at 48 h (median, 23 vs. 43 pg/ml, p = 0.04). PaCO2 and PaO2 targets did not associate with NfL levels.

CONCLUSIONS: NfL demonstrated excellent prognostic accuracy after OHCA. Higher MAP was associated with lower NfL concentrations.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Wihersaari L, Ashton NJ, Reinikainen M, et al. Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intensive Care Med. 2020. PMID: 32852582. doi:10.1007/s00134-020-06218-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。